Gladiator Giant says prostate cancer blood test could save lives
Known as Giant on the hit BBC show, the bodybuilder has been raising money for Prostate Cancer UK and took part in The Big Golf Race where he played 72 holes of golf and walked more than 26 miles in a single day, completing the challenge in just under 15 hours.
This comes after his uncle, Colin Tomlinson, was diagnosed and later recovered from prostate cancer eight years ago.
A post shared by Jamie Christian (@akathegiant)
Speaking during Men's Health Week, which runs from June 9-15, he said: 'That was just a true example of it can happen to anyone, no matter how fit or healthy you are there are no warning signs for this.
'If people aren't getting the necessary checks, then it could be too late.'
Around one in eight men in the UK will get prostate cancer in their lifetime, according to Prostate Cancer UK.
It occurs when cells in the prostate start to grow in an uncontrolled way with the risk of spreading if not detected early.
One cancer screening is a PSA blood test which checks the level of prostate specific antigens in the blood and, if high, may be a sign of a prostate condition, according to the NHS website.
He said: 'By doing a simple blood test, by going to your GP and having a simple blood test to check your PSA levels, that's like the first step, and it's something really, really easy.
'It could save their life.
A post shared by Jamie Christian (@akathegiant)
'I think men, being men, we're very private individuals especially with certain body parts. So I think the stigma attached to prostate cancer is that men have to go to the doctors and have the prostate exam with the finger up the bum, without being too graphic. I think that puts a lot of people off.
'Having the knowledge of a simple blood test will give you all you need to know that is far, far more beneficial than surely finding out one day that you might have cancer.'
Because prostate cancer often does not have any symptoms, it is important to get checked especially for men over the age of 50, black men and men with a family history of prostate cancer who are at higher risk.
Christian added: 'It's much more powerful to prevent something than to have to cure it, because the cure isn't something that we can have full control over, but prevention-wise, that is in our control to go and get the necessary checks to look after our lifestyle, our diets, our activities, shall we say.
'When you put it like that, a few minutes of your day, why would you not go and do it? Peace of mind.'
The Big Golf Race is the biggest golf fundraising challenge in the UK which encourages participants to choose from the Half Marathon (36 holes and approximately 13 miles of walking), the Marathon (72 holes and over 26 miles), or the Ultra Marathon (100 holes in one day and 35 miles) to raise money and awareness for the charity.
Speaking about the sport Christian added: '(The golf course) is a great place where men can be in a safe space and talk to one another. And these conversations on a golf course are private and respected.
'I think the more people that come on board, the more people that listen, more people that talk, more people that go out and play a game of golf and have those conversations with each other, the better.
'And hopefully, the rates of the actual deaths from prostate cancer will start to fall.'
Christian is best known as Giant on the sports and entertainment show Gladiators which sees professional athletes take on contestants as they try to complete physical challenges.
Prior to being a Gladiator, he was the tallest professional bodybuilder in the world at six feet five and consumed up to 10,000 calories a day. He has since reduced his intake to around 5,000 calories.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
38 minutes ago
- Daily Mail
UK Pharmaceutical industry at risk from government's 'sky-high' rebates system
The UK's status as a leader in medical research is at risk from 'sky-high and unpredictable' repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said the rebate system – where firms repay money they make through selling medicines to the NHS – was sending 'a terrible message to international investors'. Rachel Reeves promised to support 'the UK's strengths in life sciences' and 'ensure patients get rapid access to the most clinically and cost-effective new technologies'. The Treasury plans to invest up to £520million in drug manufacturing in the next five years. Another £600million is earmarked for a health data research service to accelerate the discovery of new medicines. But Torbett said more was needed. 'Over the past decade, accounting for inflation, the NHS budget has grown by a third in real terms, while investment in the most rigorously cost-benefit-tested part of health spending – investment in the medicines needed to treat people – has fallen from around 11 per cent to 9 per cent of the health budget,' he added. And he attacked plans to increase what drug companies must repay from drug sales to 31.3 per cent, from 15.5 per cent. 'The sky-high and unpredictable payment rates send a terrible message to international investors when the UK is trying to position life sciences research and development as an engine for health and growth. For the sake of patients, the NHS and the economy, we need a commitment to bring these unsustainable rates down.'
The Independent
2 hours ago
- The Independent
Government can hit NHS waiting times targets despite scepticism, says Reeves
The Chancellor has insisted the Government can hit its NHS waiting times targets despite scepticism from some leaders. Speaking after her spending review, Rachel Reeves said the Government was confident it could hit pledges set down by the Prime Minister last year. Sir Keir Starmer said in December the NHS will carry out 92% of routine operations within 18 weeks by March 2029. However, in March this year, the NHS waiting list for hospital treatment in England rose for the first time in seven months. The Times has also reported that internal Department of Health modelling shows the NHS is on course to hit only about 80% by the end of the parliament, with officials suggesting anything above that is overly optimistic. Asked about the pledge on Wednesday afternoon, Ms Reeves told reporters: 'We've already delivered around three-and-a-half million additional appointments since we came to office last July. 'Waiting lists are already down by 200,000 so we are confident that we can meet our plan for change commitments because of the 3% annual increase in funding for the National Health Service. 'On top of that of course, we're investing in capital spending in the NHS, including in more scanners, but also investment in the NHS digital app to make it easier for patients to access information, to book services, to take some of the costs out of the bureaucracy, as well in running our health service.' Earlier, the 3% increase in real terms for the health service per year in the spending review was welcomed by health leaders but there were warnings it is not enough. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, said the NHS funding boost was welcome, 'given the precarious state of public finances and will help the NHS to cope with rising demand from an aging population, often with multiple or more complex physical and mental health conditions'. But he warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Mr Taylor said NHS leaders will need continued backing from the Government to redesign services and balance budgets. 'That means getting political backing when some services are redesigned or cut, including moving hospital services into the community and closer to people's homes as part of the Government's three shifts,' he said. He added that the 'flat settlement' from the Chancellor 'continues to leave a major shortfall in capital funding, and it also fails to lift the ban on private investment that is required to boost NHS capital funding'. There is currently an almost £14 billion maintenance backlog bill to repair NHS hospitals and buildings. Mr Taylor said those issues needed to be addressed in the upcoming national infrastructure strategy and 10-year plan for the health service. Government documents accompanying the spending review show that, on average, from 2023-24 to 2028-29, the NHS in England will receive 3% real terms growth in day-to-day spending, equivalent to a £29 billion real terms increase in annual budgets. The Department of Health and Social Care (DHSC) budget will increase by £2.3 billion in real terms by 2029-30, compared with 2023-24, 'representing a more than 20% real terms increase by the end of the spending review period', the documents said. Overall, the figures suggest DHSC spending will rise 2.8%, though this is less than the average 3.6% in recent years. Sarah Woolnough, chief executive of the King's Fund charity, said the 2.8% average increase in DHSC spending – or 3% for day-to-day NHS spending – 'will have been hard-fought for in the spending round negotiations, despite still being lower than the historical average the NHS has received over recent years'. She added: 'We know there are already trade-offs happening in the NHS due to tight finances. 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times; more GP appointments; and adequate mental health services and more; can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.' According to spending review documents, the Government expects the NHS to deliver 2% productivity growth each year, 'unlocking £17 billion savings over three years' to reinvest back into the NHS to improve patient care. The Government will also invest up to £10 billion in NHS technology and digital transformation by 2028‑29, the documents showed. NHS England boss Sir Jim Mackey, speaking at the NHS ConfedExpo conference in Manchester, said the NHS has done 'really well relative to other parts of the public service'. He added: 'But we all know it's never enough because of the scale of advancement, all the ambition, all things we want to do, the day-to-day cost pressures we're trying to get on top of, etc. 'We're always going to be in a world where we want more money, but I think everyone's starting to accept and understand that we've got what the country can afford to give us. 'We really need to get better value for that money – it is broadly the equivalent of the GDP of Portugal, so it's a huge amount of money by any standards.' NHS England has already budgeted a 2.8% increase in pay for staff in 2025-26, but many leaders the King's Fund spoke to were worried about funding pay rises above this amount. After the spending review, Royal College of Nursing (RCN) general secretary, Professor Nicola Ranger, said staff will now decide whether the 3.6% pay rise offered by the Government is enough. She added: 'Against a backdrop of other cuts, nursing staff will see the NHS being protected but not transformed by today's spending plans. 'When the Government lays out its vision for the future of the NHS and its workforce, it must say how it intends to reverse collapsing student recruitment, boost retention and deliver urgent, structural reform to nursing pay.' Nuffield Trust senior policy analyst, Sally Gainsbury, said: 'Compared to the settlements for other departments – from policing to education – the NHS deal looks generous. 'But seen in the context of all the promises made by the Government to the British people – to drive down waiting lists, shift care closer to home, rapidly improve tech – and the commitments to meet staff pay demands and rising costs of new drugs, today's settlement soon melts away. 'With capital funding staying flat in real terms for the rest of the spending review period, it will be difficult for the NHS to invest in the technology and facility upgrades it needs to meet the Government's ambitious productivity targets.'
North Wales Chronicle
2 hours ago
- North Wales Chronicle
NHS should ‘tear up the outpatient model'
Around 130,000,000 outpatient appointments – procedures or appointments which take place in hospitals or clinics but do not require an overnight stay – take place in the NHS in England every year. The majority of people on the NHS waiting list are waiting for outpatient appointments. An estimated 7.42 million treatments were waiting to be carried out at the end of March, relating to 6.25 million patients, according to official figures. The latest performance figures for the NHS in England are due to be published on Thursday. Sir Jim Mackey, chief executive of NHS England, told the NHS ConfedExpo conference that the service should take 'big leaps' such as 'tearing up the outpatient model' and 'tearing up the frustrations about technology' and 'tearing up the multiple touch points for patients when it should be one'. And Dr Penny Dash, chairwoman of NHS England, told delegates: 'There are seven and a half million people on the waiting list, half of them waiting more than 18 weeks, and the majority of those people waiting for an outpatient appointment. 'Surely we can fix outpatients to help bring down the waiting list.' Matthew Taylor, chief executive of the NHS Confederation, said: 'Outpatient services should and could be transformed with most checks and follow-ups done in neighbourhoods or remotely.' Meanwhile, Sir Jim said the NHS has 'lost its way' on quality of care, as he told delegates that the forthcoming 10-year plan for health, which is to be published in July, will 'focus on quality'. 'Neighbourhood care – I think that part of the plan is still a really big standout for me,' he said. 'The focus on quality, I think it's really welcome – we have lost our way a little bit on quality coming out of Covid, and again, looking at quality in the round and not just safety.' But he said that the NHS would move on from the 'over-prescription centrally' and the 'labyrinthine approval processes' to give local health leaders more freedom. Dr Dash added: 'We do need to have a comprehensive strategy for quality. 'We've had a big focus on safety, rightly, over the last 10 years, but that has been a bit at the expense of patient experience and also effectiveness. We need to regroup, set out that strategy.'
